|
Delayed
Canadian Securities Exchange
09:50:03 2026-10-27 am EDT
|
5-day change | 1st Jan Change | ||
| 0.4800 CAD | 0.00% |
|
-4.00% | -31.43% |
| Oct. 21 | Grown Rogue International Increases Ownership Interest in New Jersey Subsidiary to 70% | MT |
| Oct. 19 | Grown Rogue International Inc. acquired an additional 26% stake in ABCO Garden State, LLC. | CI |
| Market Cap | 85.58M 76.52M 70.8M 64.1M 120M 8.14B 122M 852M 337M 4.26B 321M 314M 13.48B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 101M 90.2M 83.45M 75.56M 141M 9.6B 144M 1B 397M 5.02B 379M 371M 15.89B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 week | -4.00% | ||
| Current month | -18.64% | ||
| 1 month | -26.15% | ||
| 3 months | -7.69% | ||
| 6 months | -3.03% | ||
| Current year | -31.43% |
| 1 week | 0.47 |  | 0.55 |
| 1 month | 0.47 | | 0.66 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 2024-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.00% | -7.69% | +20.00% | 85.58M | |
| +0.22% | +0.02% | +55.36% | +129.18% | 1,140B | |
| +0.29% | +3.08% | +40.48% | +83.61% | 641B | |
| -0.47% | -1.09% | +25.40% | +105.82% | 507B | |
| -0.29% | +1.46% | +47.94% | +66.39% | 383B | |
| +0.13% | -5.12% | +59.89% | +36.84% | 347B | |
| +0.89% | +2.36% | +25.51% | +54.58% | 293B | |
| -0.45% | +1.42% | +2.00% | +26.40% | 266B | |
| -0.12% | +1.24% | +52.62% | +69.89% | 240B | |
| -1.02% | +0.29% | +30.30% | +104.87% | 197B | |
| Average | -0.07% | +2.04% | +33.18% | +69.76% | 401.39B | |
| Weighted average by Cap. | +0.03% | +2.98% | +41.78% | +87.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 24.16M 22.35M 20.24M 37.88M 2.57B 38.5M 269M 106M 1.34B 101M 99.23M 4.26B | 32.43M 29M 26.83M 24.29M 45.46M 3.09B 46.21M 323M 128M 1.61B 122M 119M 5.11B |
| Net income | -11.3M -10.11M -9.35M -8.47M -15.85M -1.08B -16.11M -113M -44.51M -562M -42.42M -41.52M -1.78B | 1.73M 1.55M 1.43M 1.3M 2.43M 165M 2.46M 17.22M 6.81M 86.08M 6.49M 6.35M 273M |
| Net Debt | 3.7M 3.31M 3.06M 2.77M 5.19M 352M 5.28M 36.88M 14.59M 184M 13.9M 13.61M 584M | 15.3M 13.68M 12.66M 11.46M 21.45M 1.46B 21.8M 152M 60.25M 761M 57.42M 56.19M 2.41B |
Employees
-
Sector
Pharmaceuticals
Calendar
Nov. 12
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | CA$0.4800 | 0.00% | 4,500 |
| 26-10-26 | CA$0.4800 | 0.00% | 3,000 |
| 26-10-23 | CA$0.4800 | -2.04% | 10,000 |
| 26-10-22 | CA$0.4900 | -5.77% | 59,299 |
| 26-10-21 | CA$0.5200 | +4.00% | 21,600 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
